Connection

W. Garvey to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications W. Garvey has written about Clinical Trials, Phase III as Topic.
W. Garvey
Connection Strength
0.134
Clinical Trials, Phase III as Topic
  1. Cardiometabolic Disease Staging Predicts Effectiveness of Weight-Loss Therapy to Prevent Type 2 Diabetes: Pooled Results From Phase III Clinical Trials Assessing Phentermine/Topiramate Extended Release. Diabetes Care. 2017 07; 40(7):856-862.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.